58 research outputs found

    Cerebral stroke in a teenage girl with paroxysmal nocturnal hemoglobinuria

    Get PDF
    We report a case of paroxysmal nocturnal hemoglobinuria (PNH) in a 14 year-old girl presenting a cerebral arterial thrombosis. The initial diagnosis was carential anemia due to menarche following identification of slight macrocytic anemia, leucopenia and mild thrombocytopenia at routine blood analysis. The child was eventually referred to a children’s hospital after the onset of progressive fatigue, anorexia and paleness. Severe anemia (hemoglobin 6 g/dL) with negative Coombs test, mild leucopenia (white blood cells 4.9×109/L) and thrombocytopenia (platelets 97×109/L) and high values of lactate dehydrogenase (2855 U/L) were identified; a packed red cells transfusion was administered. Her condition worsened and she subsequently presented complete right hemiplegia, aphasia and coma; magnetic resonance imaging revealed a massive ischemic lesion. A diagnosis of PNH was eventually made following high sensitivity flow cytometry, which identified a PNH clone (CD66b negative equal to 93.7% of granulocytes). Fast recovery from neurologic and hematological problems occurred in response to anticoagulant therapy and intravenous therapy with eculizumab. We are convinced that PNH should be included in the differential diagnosis of children presenting with cytopenia

    Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing–remitting multiple sclerosis patients

    Get PDF
    Background and objectivesMultiple sclerosis (MS) is a chronic, progressive neurological disease characterized by early-stage neuroinflammation, neurodegeneration, and demyelination that involves a spectrum of heterogeneous clinical manifestations in terms of disease course and response to therapy. Even though several disease-modifying therapies (DMTs) are available to prevent MS-related brain damage—acting on the peripheral immune system with an indirect effect on MS lesions—individualizing therapy according to disease characteristics and prognostic factors is still an unmet need. Given that deregulated miRNAs have been proposed as diagnostic tools in neurodegenerative/neuroinflammatory diseases such as MS, we aimed to explore miRNA profiles as potential classifiers of the relapsing–remitting MS (RRMS) patients’ prospects to gain a more effective DMT choice and achieve a preferential drug response.MethodsA total of 25 adult patients with RRMS were enrolled in a cohort study, according to the latest McDonald criteria before (pre-cladribine, pre-CLA; pre-ocrelizumab, pre-OCRE, time T0) and after high-efficacy DMTs, time T1, 6 months post-CLA (n = 10, 7 F and 3 M, age 39.0 ± 7.5) or post-OCRE (n = 15, 10 F and 5 M, age 40.5 ± 10.4) treatment. A total of 15 age- and sex-matched healthy control subjects (9 F and 6 M, age 36.3 ± 3.0) were also selected. By using Agilent microarrays, we analyzed miRNA profiles from peripheral blood mononuclear cells (PBMC). miRNA–target networks were obtained by miRTargetLink, and Pearson’s correlation served to estimate the association between miRNAs and outcome clinical features.ResultsFirst, the miRNA profiles of pre-CLA or pre-OCRE RRMS patients compared to healthy controls identified modulated miRNA patterns (40 and seven miRNAs, respectively). A direct comparison of the two pre-treatment groups at T0 and T1 revealed more pro-inflammatory patterns in the pre-CLA miRNA profiles. Moreover, both DMTs emerged as being capable of reverting some dysregulated miRNAs toward a protective phenotype. Both drug-dependent miRNA profiles and specific miRNAs, such as miR-199a-3p, miR-29b-3p, and miR-151a-3p, emerged as potentially involved in these drug-induced mechanisms. This enabled the selection of miRNAs correlated to clinical features and the related miRNA–mRNA network.DiscussionThese data support the hypothesis of specific deregulated miRNAs as putative biomarkers in RRMS patients’ stratification and DMT drug response

    XII Seminar - PhD Day Happiness is a simple system

    No full text
    The last meeting of PhD students in Infectious Diseases, Microbiology and Health has been strongly influenced by, and focused on the COVID-19 pandemic. The XII meeting tries to get out from the emergency, with invited talks dedicated to two aspects: happiness and simplicity/complexity. Happiness is intended as the including the comprehensive concept of well-being, while the contrasting simple/complex dichotomy is a paradigm of biological systems that requires both complex interactions and simple adaptive solutions

    Molecular identification of bot flies (Cuterebra baeri) infesting grey-legged night monkeys (Aotus griseimembra) and howler monkeys (Alouatta seniculus) in Colombia

    No full text
    Myiasis is a neglected parasitosis caused by infection with the larval stages of some fly species. In neotropical non- human primates (NHP) three bot fly species causing cutaneous myiasis have been reported: Cuterebra baeri in Alouatta belzebul, Aotus trivirgatus, Alouatta seniculus, and Alouatta palliata (Guimarães, 1971; De Thoisy et al. 2001; Cristobal- Azkarate et al. 2012), Cochliomyia hominivorax in A. seniculus and Pithecia pithecia (Vie & Richard-Hansen, 1997), and Dermatobia hominis in A. palliata and Saguinus mystax (Smith, 1977; Herrera & Heyman, 1998), along with Dermatobia sp. parasitizing Aotus sp. (Tantalean et al. 1990). Studies on myiasis in NHP are scarce and mainly based on larval morphological identification, while molecular approaches have been barely used. In Colombia, Cuterebra sp. has been morphologically identified in Aotus vociferans and Aotus nancymaae, in the Amazon region (Roncancio et al. 2018). This study aimed to molecularly identify bot flies parasitizing two free-ranging primate species living sympatrically in central Colombia. Sampling was conducted in a lowland rainforest fragment in Santander, Colombia. Four bot fly larvae were collected from two grey-legged night monkeys (Aotus griseimembra) and one from a howler monkey (Alouatta seniculus). Larvae were measured and photographed, and subsequent DNA extraction and PCR amplification of a partial cox1 mitochondrial region were performed (Cavallero et al. 2017). All PCR products were visualized on an agarose gel and good quality amplicons were sequenced. Sequences were manually edited and used for BLAST search and alignment. All specimens were identified as Cuterebra baeri, according to the best match in BLAST showing 98% of identity (accession number AF497777 corresponding to specimens characterized in monkeys from Panama, Otranto et al. 2003). This is the first molecular identification of bot flies infesting NHP in Colombia, and the first record at the species level for A. seniculus and A. griseimembra in the country

    Table_3_Rat and fish peripheral blood leukocytes respond distinctively to Anisakis pegreffii (Nematoda, Anisakidae) crude extract.xlsx

    No full text
    Infective third-stage larvae (L3) of the marine nematode Anisakis pegreffii cause inflammation and clinical symptoms in humans, their accidental host, that subside and self-resolve in a couple of weeks after L3 die. To characterise the differences in an early immune response of a marine vs. terrestrial host, we stimulated peripheral blood leukocytes (PBLs) of fish (paratenic host) and rat (accidental, human-model host) with A. pegreffii crude extract and analysed PBL transcriptomes 1 and 12 h post-stimulation. Fish and rat PBLs differentially expressed 712 and 493 transcripts, respectively, between 1 and 12 h post-stimulation (false discovery rate, FDR 2). While there was a difference in the highest upregulated transcripts between two time-points, the same Gene Ontologies, biological processes (intracellular signal transduction, DNA-dependent transcription, and DNA-regulated regulation of transcription), and molecular functions (ATP and metal ion binding) were enriched in the two hosts, showing an incrementing dynamic between 1 and 12 h. This suggests that the two distinct hosts employ qualitatively different transcript cascades only to achieve the same effect, at least during an early innate immunity response. Activation of later immunity elements and/or a combination of other host’s intrinsic conditions may contribute to the death of L3 in the terrestrial host.</p

    Table_1_Rat and fish peripheral blood leukocytes respond distinctively to Anisakis pegreffii (Nematoda, Anisakidae) crude extract.xlsx

    No full text
    Infective third-stage larvae (L3) of the marine nematode Anisakis pegreffii cause inflammation and clinical symptoms in humans, their accidental host, that subside and self-resolve in a couple of weeks after L3 die. To characterise the differences in an early immune response of a marine vs. terrestrial host, we stimulated peripheral blood leukocytes (PBLs) of fish (paratenic host) and rat (accidental, human-model host) with A. pegreffii crude extract and analysed PBL transcriptomes 1 and 12 h post-stimulation. Fish and rat PBLs differentially expressed 712 and 493 transcripts, respectively, between 1 and 12 h post-stimulation (false discovery rate, FDR 2). While there was a difference in the highest upregulated transcripts between two time-points, the same Gene Ontologies, biological processes (intracellular signal transduction, DNA-dependent transcription, and DNA-regulated regulation of transcription), and molecular functions (ATP and metal ion binding) were enriched in the two hosts, showing an incrementing dynamic between 1 and 12 h. This suggests that the two distinct hosts employ qualitatively different transcript cascades only to achieve the same effect, at least during an early innate immunity response. Activation of later immunity elements and/or a combination of other host’s intrinsic conditions may contribute to the death of L3 in the terrestrial host.</p
    • 

    corecore